How can inspectors mitigate the risks associated with inspections during COVID?
Pharmaceutical Inspection Co-operation Scheme (PIC/S) recently published risk assessment for on-site inspections: “COVID-19 RISK ASSESSMENT FOR NATIONAL ROUTINE ON-SITE INSPECTIONS.” This article provides an overview of the key topics in PIC/S’s risk assessment. Readers are encouraged to consult the original document and relevant information sources for detailed information. A risk assessment is a systematic […]